Paper42909166PubMed
Long COVID is associated with lipoxygenase-catalyzed metabolism of essential polyunsaturated fatty acids.
Moss ME and 8 others. iScience, 2026.
Cite this record
ConductScience Library. Long COVID is associated with lipoxygenase-catalyzed metabolism of essential polyunsaturated fatty acids. Papers, record 42909166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42909166
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long COVID is associated with lipoxygenase-catalyzed metabolism of essential polyunsaturated fatty acids.
- Journal
- iScience
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-25
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| S10 OD032292 | NIH HHS | United States | S10OD032292 | PubMed | NIH RePORTER |
| S10 RR027926 | NCRR NIH HHS | United States | S10RR027926 | PubMed | NIH RePORTER |
References67
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4215079 | Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4215079 | PubMed |
| 2 | 39580033 | The effect of pre-COVID and post-COVID vaccination on long COVID: A systematic review and meta-analysis. | J Infect | 2024 | https://conductscience.org/library/papers/39580033 | PubMed |
| 3 | 40100623 | Deficiency in platelet 12-lipoxygenase exacerbates inflammation and disease severity during SARS-CoV-2 infection. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40100623 | PubMed |
| 4 | 34787883 | Acute severe SARS COVID-19 patients produce pro-resolving lipids mediators and eicosanoids. | Eur Rev Med Pharmacol Sci | 2021 | https://conductscience.org/library/papers/34787883 | PubMed |
| 5 | 34489955 | Protectins PCTR1 and PD1 Reduce Viral Load and Lung Inflammation During Respiratory Syncytial Virus Infection in Mice. | Front Immunol | 2021 | https://conductscience.org/library/papers/34489955 | PubMed |
| 6 | 21838667 | 12-lipoxygenase: a potential target for novel anti-platelet therapeutics. | Cardiovasc Hematol Agents Med Chem | 2011 | https://conductscience.org/library/papers/21838667 | PubMed |
| 7 | 39303274 | Proresolving Lipid Mediators in the Respiratory System. | Annu Rev Physiol | 2025 | https://conductscience.org/library/papers/39303274 | PubMed |
| 8 | 28775075 | First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis. | Arterioscler Thromb Vasc Biol | 2017 | https://conductscience.org/library/papers/28775075 | PubMed |
| 9 | 12590139 | Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12590139 | PubMed |
| 10 | 39907495 | Long COVID Incidence Proportion in Adults and Children Between 2020 and 2024: An Electronic Health Record-Based Study From the RECOVER Initiative. | Clin Infect Dis | 2025 | https://conductscience.org/library/papers/39907495 | PubMed |
| 11 | 37433819 | Long COVID prevalence and impact on quality of life 2 years after acute COVID-19. | Sci Rep | 2023 | https://conductscience.org/library/papers/37433819 | PubMed |
| 12 | 36456834 | Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. | Nat Med | 2023 | https://conductscience.org/library/papers/36456834 | PubMed |
| 13 | 26688348 | Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. | Nat Rev Immunol | 2016 | https://conductscience.org/library/papers/26688348 | PubMed |
| 14 | 34111579 | Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. | Clin Microbiol Infect | 2021 | https://conductscience.org/library/papers/34111579 | PubMed |
| 15 | 39198441 | Early biological markers of post-acute sequelae of SARS-CoV-2 infection. | Nat Commun | 2024 | https://conductscience.org/library/papers/39198441 | PubMed |
| 16 | 34425843 | Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. | Cardiovasc Diabetol | 2021 | https://conductscience.org/library/papers/34425843 | PubMed |
| 17 | 15814734 | Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. | J Immunol | 2005 | https://conductscience.org/library/papers/15814734 | PubMed |
| 18 | 8250832 | Lipoxin synthase activity of human platelet 12-lipoxygenase. | Biochem J | 1993 | https://conductscience.org/library/papers/8250832 | PubMed |
| 19 | 34007978 | Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/34007978 | PubMed |
| 20 | 41249167 | Long COVID trajectories in the prospectively followed RECOVER-Adult US cohort. | Nat Commun | 2025 | https://conductscience.org/library/papers/41249167 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42909166
GET https://conductscience.org/api/papers/v1/42909166/references?page=2